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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Hexanal, a secondary product of lipid oxidation, was identified as
the major volatile aldehyde generated from lipid peroxidation in
human milk. Hexanal was quantified in human milk using solid
phase microextraction gas chromatography/flame ionization detec 
tion that required correction for recovery based on the fat content
of human milk. Alpha tocopherol was the only tocopherol isomer
in human milk found to be significantly correlated with hexanal
(R = −0.374, p<0.05) and the total antioxidant capacity of human
milk (ORACFl (R = 0.408, p<0.01)). Ascorbic acid content was nega 
tively correlated (R = −0.403,  p<0.05) with hexanal, but not to
ORACFl in human milk. The effect of Holder pasteurization on
oxidative status of human milk was determined using multiple
parameters that included, hexanal level and malondialdehyde as
markers of lipid oxidation, vitamins C and E content and anti 
oxidant capacity (e.g. ORACFl). Pasteurization did not affect the
oxidative status of milk as measured by hexanal level, ORACFl and
malondialdehyde content. We conclude that hexanal is a sensitive
and useful chemical indicator for assessing peroxidation reactions
in human milk and that alpha tocopherol and ascorbic acid are
two key antioxidant components in milk that contribute to
protection against oxidation of milk lipids.
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Introduction The benefits of breastfeeding to infant health have been
partially attributed to the antioxidant activity of human
milk.(1,2) The incidence of necrotizing enterocolitis, an ‘oxygen
radical disease’, for example, is reduced in breastfed infants.(3)
Breastfeeding however is not always feasible and mothers can
alternatively choose to obtain milk from milk banks. Milk banks
are required to pasteurize breast milk to prevent disease trans-
mission and reduce the risk of bacterial contamination.(4,5) Pasteuri-
zation utilizes heat that may compromise the oxidative status of
milk.(6) For example, lipid oxidation reactions that occur in milk
produce a variety of peroxidation products, some of which have
been shown to contribute to the development of various ‘oxygen
radical disease states’ in infants.(3,7) Determining the extent of lipid
oxidation as an indicator for oxidative status of human milk is
therefore of strategic importance to ensure both safety and quality
of mother’s milk.
Lipid peroxidation of human milk has been studied using
numerous indices of lipid oxidation, such as the measurement of
conjugated dienes, peroxide value and malondialdehyde forma-
tion.(8,9) These methods; however, can lack specificity due to
interference with non-lipid components in the food matrix, or
have variable reactivity that depends on assay conditions.(10) The
presence of volatile carbonyl compounds in foods generated from
the decomposition of lipid hydroperoxides is an established
indicator of lipid oxidation products in some food systems, but
has not previously been used to quantitate the onset of lipid
oxidation in human milk. Factors that may impede the progression
of lipid oxidation in human milk include the presence of anti-
oxidant vitamins, E and C. While we have previously established
that α-tocopherol (Toc), the predominant tocopherol isomer present
in breast milk, is significantly related to the free radical scavenging
capacity of human milk,(11) there is no information on how vitamin
E and related tocopherol isomers correlate with specific peroxida-
tion reaction products in human milk.
The objective of this study was to first develop a method for
identifying and quantifying the volatile aldehyde content in human
milk and then to determine the relative contribution of vitamins E
and C in protecting against lipid oxidation in human milk. Further-
more, the effect of pasteurization on the oxidative status of milk
was determined using volatile oxidation products as the primary
indicator of lipid oxidation, and malonaldehyde content as well as
total antioxidant capacity (TAC) using ORACFL.
Materials and Methods
Materials. All reagents were purchased from Sigma-Aldrich,
Canada (Oakville, ON, Canada) unless otherwise mentioned.
Mature human milk samples, defined as milk obtained two weeks
after birth, were collected from ten apparent non-smoking, uni-
parous mothers over thirty different lactation dates. Participants
were instructed to collect a milk sample expressed after five
minutes of nursing (hindmilk). The milk was immediately frozen
at −80°C upon arrival in the laboratory until analysis, which was
analyzed in batches no later than 2 weeks after collection. All the
donors gave informed consent to participate in the study. This
study was reviewed and approved by the University of British
Columbia Ethical Review Board Committee.
Holder pasteurization of milk samples. The Holder 
pasteurization technique (62.5°C at 30 min), as recommended
by the Human Milk Bank Association of North America(4) was
used in this study. Aliquots of milk samples were thawed and
pasteurized shortly thereafter at 62.5°C for 30 min. Pasteurized
milk was immediately chilled and analyzed.
Analysis of fat content and fatty acid composition.
Milk fat was measured using a creamatocrit centrifuge (IEC
Model MB centrifuge) for 5 min, and the fat content was deter-
mined with an IEC micro-capillary reader (International Equip-
ment Company, Needham Heights, MA). Fatty acid analysis of
individual milk samples was performed on milk fatty acid methyl
esters (FAME), analyzed by GC equipped with a capillary column
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(30 m × 0.25 mm; 0.25 μm film thickness; liquid phase: J&W
DB 23).(12)
Analysis of milk fat volatiles. Thawed milk samples, pre-
conditioned to room temperature were vortexed to ensure homo-
geneity prior to transfer to a 10 ml vial containing 1.5 g of salt.
Samples were equilibrated at 25°C with continuous stirring for
15 min using a micro stir bar. Headspace volatiles were then
sampled using SPME fiber (100 μm PDMS, Supelco, Bellefonte,
PA) for 20 min followed by injection in splitless mode to Agilent
6890A GC coupled with Agilent 5973 mass selective detector.
Adsorbed volatiles were desorbed to a Hewlett Packard HP-5
column (30 m × 0.25 mm i.d., 0.25 μm film thickness) at initial
column temperature of 40°C that was held for 2 min, followed
by an increase to 60°C at 15°C/min and a further increase to 300°C
at 40°C/min, then held for 6 min. The carrier gas was hydrogen set
at a flow rate of 40 cm/sec. Injection and detector temperatures
were 250°C and 300°C, respectively. GC/MS ionization voltage
was set at 70 eV. Identification of volatiles was performed by
comparison of mass spectra to those found in Wiley7/NIST05
library database.
To quantify hexanal in milk samples, volatiles were sampled as
described above and identified in split less mode using an Agilent
6890A GC-Flame Ionization Detector. External standard curves
for hexanal were constructed and 4-heptanone was used as the
internal standard. The recoveries of hexanal were made by spiking
the milk samples with 0.2 ppm of the aldehyde.
Analysis of malondialdehyde (MDA) in milk. MDA con-
centrations in raw and pasteurized milk samples were determined
as according to the method of Nielsen et al.(13) Milk was mixed
with 1% ortho-phosphoric acid, and a 42 mM solution of thiobar-
bituric acid (TBA). Upon vortexing, samples were heated at
100°C for 1 h and the reaction was stopped by cooling on ice for
10 min. Heated samples were transferred to micro-centrifuge
tubes containing 300 μl of 2 N NaOH: MeOH (1:12, v/v) solution
and centrifuged for 10 min at 10,000 rpm. The supernatant was
filtered through a 0.2 μm Nylon membrane and 50 μl was injected
onto HPLC (Agilent 1100, Palo Alto, CA) equipped with a Luna
column (5 μm, 150 × 4.6 mm, Phenomenex, Torrance, CA). An
isocratic mobile phase consisting of 48% methanol and 52%
potassium phosphate buffer (50 mM, pH 6.0) was used to separate
the MDA-TBA complex. MDA was quantified at 532 nm, based
on external standard 1,1,3,3-Tetraethoxypropane (TEP); which
stoichiometrically produced MDA upon acid hydrolysis.
Analysis of tocopherol isomers milk. Toc isomers in 
human milk were determined using HPLC (Agilent Technology
1100 series, Palo Alto, CA) with fluorescence detection as previ-
ously described.(11) Briefly, 500 μl of milk was diluted with 500 μl
of water followed by the addition of 500 μl of ethanol to precipi-
tate milk protein. Milk samples were extracted twice with 2 ml of
hexane and extracts evaporated under a stream of nitrogen. The
residue was reconstituted in 100 μl of methanol, and the sample
was filtered through a 0.2 μm Nylon membrane into an amber
HPLC vial for injection. Separation of tocopherol isomers was
performed using a 3 μm Sphereclone column (150 mm × 4.6 mm,
Phenomenex, Torrance, CA) with methanol as mobile phase
(1 ml/min). Tocopherol isomers were identified using fluores-
cence detection (e.g. excitation wavelength = 292 nm; emission
wavelength = 330 nm).
Analysis of total ascorbic acid in milk. Total ascorbic acid
in milk was determined according to the method of Francis et al.(14)
Samples were mixed with one ml of 100 mM DL-dithiothreitol by
mechanical inversion for 30 sec in amber microcentrifuge tubes
and treated with 400 μl of 0.56% metaphosphoric acid. The mixture
was shaken for 30 sec, centrifuged at 10°C, 10,000 rpm and
supernatants filtered prior to injection onto HPLC. Ascorbic acid
was quantified using a Zorbax RX-C18 5 μm column (250 × 4.6
mm) at 45°C and a mobile phase of 0.1 M NaH2PO4 (pH 2.5)
buffer at 1.5 ml/min and ascorbic acid was detected at 254 nm.(14)
Analysis of total antioxidant capacity (TAC). TAC of
human milk was determined using the Oxygen Radical Absor-
bance Capacity–ORACFL assay.(15) Values were expressed as
μmole of Trolox Equivalent/mL of milk sample.
Statistical analysis. Creamatocrit and GC-FID measure-
ments of milk samples were performed in duplicate, while
ORACFL assay, MDA analysis, vitamins C and E concentrations
in milk were performed in triplicate. A paired t test was performed
to identify significant differences in lipid oxidation and anti-
oxidant capacity between pasteurized and raw milk. The Pearson
correlation coefficient between antioxidant components and end
point measures of oxidative status in milk was determined using
Graph-Pad Prism version 3.02 (La Jolla, CA) statistical software.
Results
Fat composition, total ascorbic acid and tocopherol isomers
level. The fat content of the milk samples varied considerably
(1.5–8.5%) between samples, collected from different mothers,
with an overall average of 5.52% calculated for all samples
(Table 1). Oleic acid was the predominant fatty acid (34.97 ±
5.21%), followed by linoleic acid (19.01 ± 5.12%) and palmitic
acid (15.44 ± 1.39%) in mother’s milk. Linolenic acid constituted
less than 2% (e.g. 1.48 ± 0.48%) of the total fatty acids. Alpha
tocopherol was the dominant tocopherol isomer, followed by γ-
and  δ-tocopherol in respective order (Table 1). Ascorbic acid
was also present in a wide range of concentrations (e.g. ND–67.95
μg/ml) in different individual mother’s milk samples.
Identification of volatile aldehydes from human milk.
Alkanals identified in human milk included pentanal, hexanal,
octanal, nonanal and 2-octenal, and dodecanal (Fig. 1); relative
concentrations of each aldehyde varied in individual milk samples.
Hexanal, was present in the highest abundance relative to other
identified alkanals. Other non-alkanal volatiles identified in human
milk included short chain hydrocarbons, chlorinated compounds
such as 1-chloropentane and other benzene-containing compounds
that were identified to be dichlorobenzene and cyclohexane (Fig. 1).
Quantification of alkanals from milk samples. The use of
4-heptanone as internal standard for the quantification of alkanals
from human milk was found to be unsuccessful, largely due to
inconsistent recovery of 4-heptanone in all milk samples and
poor relationship to the recovery of hexanal (Fig. 2). Preliminary
experiments determined that the recovery of 4-heptanone from
human milk was correlated with the fat content (R = −0.792,
p<0.05), but not with the protein content (R = 0.2506, p>0.05).
Similar incomplete recoveries of pentanal and hexanal when
spiked at 0.2 ppm to milk were found in milk samples that had
high fat content (Fig. 3). The inverse relationship between fat
content and the recovery of the alkanals followed a linear trend
Table 1. Lipid profile and relevant antioxidant components of human
milk samples analyzed in this study†
† Total number of milk samples (n = 30).
Milk Parameter Mean ± SD Range
Fat (%) 5.52 ± 1.85 1.5–8.5
Mono unsaturated (%) 42.94 ± 6.38 29.92–50.49
Oleic acid 34.97 ± 5.21 26.26–41.78
Poly unsaturated (%) 23.88 ± 5.36 19.02–33.48
Linoleic acid 19.01 ± 5.12 14.53–28.62
Linolenic acid 1.48 ± 0.48 0.84–2.23
Antioxidant components (μg/mL)
α tocopherol 2.11 ± 0.66 1.21–4.62
γ tocopherol 0.80 ± 0.28 0.26–1.43
δ tocopherol 0.14 ± 0.07 0.05–0.33
Total ascorbic acid 21.70 ± 19.29 0–67.95 J. Clin. Biochem. Nutr. | November 2011 | vol. 49 | no. 3 | 149
©2011 JCBN
I. Elisia et al.
for hexanal (R = −0.968,  p<0.05, Fig. 4). To quantify hexanal
therefore, we chose to determine the recovery rate of hexanal
rather than the internal standard as the degree of recovery may
differ depending on the properties of the aldehyde. Quantification
of hexanal in mother’s milk was made from the area under the
curve derived from the chromatogram corrected for the percent
recovery of hexanal based on the fat content of milk using a linear
regression (y = −0.21975x + 20.935) that equated the fat content
of milk with the percent recovery of hexanal, where y is the %
recovery of the hexanal, and × is the fat content (%). The average
concentration of hexanal obtained from the external standard
curve and corrected for recovery in all human milk samples was
0.285 ± 0.230 ppm. The limit of detection for hexanal using
SPME-GC/FID was determined to be 0.14 ppt.
Relationship of antioxidant components to oxidative
status of milk. To determine the possible contribution of
specific antioxidant components present in human milk to protect
against lipid oxidation, we determined the hexanal concentrations
in milk, normalized for fat content, and then correlated this para-
meter with the concentration of individual tocopherol isomers or
vitamin C. Amongst all tocopherol isomers, only α-tocopherol
was significantly, and inversely, correlated with the concentration
of hexanal in milk fat (Table 2). Ascorbic acid content in milk was
also inversely related with hexanal concentration (R = –0.403,
p<0.05; Table 2). No significant relationship was found between
MDA content and any of the antioxidant components investigated
in mother’s milk samples. ORACFL values, were significantly
Fig. 1. Volatiles identified from milk samples by SPME GC/MS. Compounds identified are 1. CO2; 2. 2 methyl 2 propanol; 3. Cyclohexane; 4.
Hexane; 5. 2 ethoxy 2 methyl propane; 6. 4 methyl 1 heptanol; 7. Pentanal; 8. 1 chloropentane; 9. 4 methyl heptane; 10. Hexanal; 11. 2,4 dimethyl 
heptane; 12. 2,4 diethyl 1 heptene; 13. Heptanal; 14. Hexanoic acid; 15. Octanal; 16. Dichlorobenzene; 17. 3 ethyl 2 methyl 1,3 hexadiene; 18. 2 octenal;
19. Nonanal; 20. Octanoic acid; 21. 1,4 di tert butyl benzene; 22. Decanoic acid; 23. Dodecanal.
Fig. 2. Results of 4 heptanone (internal standard) recovered from
representative milk samples chosen with distinct fat contents. Milk
samples were spiked with 0.2 ppm internal standard. Fig. 3. Regression analysis of the recovery of hexanal from human
milk affected by fat content. Milk samples were spiked with 0.2 ppm
hexanal for recovery purposes.doi: 10.3164/jcbn.10 142
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(p<0.05) correlated only with α-Toc levels (R = 0.408, p<0.01),
with no significant relationship observed with total ascorbic acid
concentration.
Effect of pasteurization on oxidative status of milk.
Holder pasteurization of human milk did not significantly affect
the antioxidant capacity of human milk as determined by the
ORACFL assay (Table 3). The average concentration of hexanal
and MDA in all human milk samples was also not significantly
altered by pasteurization (Table 3). However, higher hexanal
concentrations were observed in two individual human milk
samples following pasteurization that showed no effect on MDA
content. Of particular interest was the observation that two milk
samples which had relatively high concentrations of  hexanal also
contained extremely low vitamin C contents (<8.5 μg/ml).
Discussion
Hexanal is a decomposition product of linoleic acid(16) and in
this study it was found to be the major aldehyde generated from
lipid oxidation of human milk. Pentanal was also detected in
mother’s milk, albeit in lesser quantity, and represents another
peroxidation product derived from linoleic acid. Despite the fact
that oleic acid is the main fatty acid in human milk, the generation
of octanal and nonanal, which represents decomposition products
of oleic acid were negligible in comparison to that found for
hexanal. This finding can be attributed to the relatively greater
susceptibility of linoleic acid to lipid oxidation, compared to oleic
acid.(10)
In a preliminary experiment, we determined that hexanal was
the primary product generated in human milk samples following a
forced peroxidation that involved treatment with extended heat
exposure (50°C for 24 h) and measurement by static headspace
GC (Fig. 5). Pentanal, another volatile generated from oxidation
of linoleic acid was also present in forced peroxidized samples;
however this occurred at lesser concentrations and with consider-
able variability that in fact compromised its use as a reliable
indicator of lipid oxidation. Our parallel experiment established
that hexanal was the primary product of hydroperoxide decom-
position of human milk fat. Static headspace GC was found to be
insufficiently sensitive to detect hexanal in fresh milk samples,
which lead us to use SPME-GC/FID as the preferred method
of analysis. For example, by comparison, the signal to noise
ratio for hexanal in our SPME-GC/FID method was found to be
approximately 50 times greater than that established using static
headspace (data not shown). This SPME-GC/FID procedure
proved to be a reliable and more sensitive method for the quantifi-
Fig. 4. Recovery of pentanal, hexanal and 4 Heptanone (internal
standard) in milk samples of varying fat content as determined using
GC FID. The peaks are obtained by subtracting the chromatogram
obtained for milk spiked with 0.2 ppm of internal standard with the
chromatogram of unspiked milk.
Table 2. Correlation of lipid oxidation products with antioxidant parameters in human milk‡
*denotes significant correlation at p<0.05 (n = 30). ‡Hexanal and MDA variables were adjusted to the fat content of the respective milk samples.
Lipid oxidation products α Toc γ Toc δ Toc vit. C ORACFL
Hexanal –0.374* –0.026 0.143 –0.403* 0.169
MDA –0.304 –0.161 –0.001 –0.525 0.556
Table 3. Effect of pasteurization on oxidative status of human milk (n =3 0 ) 1
1 (n = 30). ‡ns = No significant difference.
Parameter
Fresh Pasteurized
Difference‡
Mean ± SD Mean ± SD
ORACFL (μmole Trolox Eq./mL) 3.12 ± 0.84 3.00 ± 0.75 ns
Hexanal (ppm) 0.285 ± 0.230 0.312 ± 0.213 ns
Malondialdehyde (μM) 0.26 ± 0.17 0.25 ± 0.16 ns J. Clin. Biochem. Nutr. | November 2011 | vol. 49 | no. 3 | 151
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cation of hexanal in both fresh and pasteurized human milk;
producing reliable data that could be employed as a chemical
indicator of lipid oxidation in human milk samples.
Quantification of alkanals from human milk samples however,
poses a unique challenge that is not often encountered in many
common food materials. In order to quantify hexanal from a food
matrix, it is ideal that a standard curve is constructed in a matrix
that has an identical composition to the test sample. In the specific
case of mother milk samples, the matrix represents a complex
biological material that can have a wide range of solute compo-
nents and concentrations that vary depending on many factors,
such as time of lactation, inherent differences between mothers, as
well as dietary habits.(17) For example, the fat content of the human
milk samples in this study ranged from 1.5% to 8.5%. We demon-
strate herein, that the recovery of hexanal is highly dependent on
the fat content of the milk, suggesting that to accurately quantify
hexanal from human milk, a standard curve is required for different
concentrations of fat content. Spiking human milk samples
containing different fat content with the same amount of hexanal,
enabled a more accurate recovery of hexanal to be determined.
The relationship between fat content in milk and hexanal recovery
was found to be adequately corrected by using a linear regression
equation constructed between the fat content of milk and the
recovery of hexanal in the same sample.
Other workers have indicated that the presence of primary
lipid oxidation products such as peroxides, conjugated diene and
TBARS in mother’s milk are not associated with vitamin E
content.(9) Our finding shows that an inverse relationship does
exist between lipid oxidation and the α-Toc isomer of vitamin E
when using hexanal as the end-point measure of lipid oxidation.
Amongst all Toc isomers, only α-Toc isomer was inversely corre-
lated with TAC as measured by ORAC assay, which supports our
previous finding.(11) An explanation for this could be due to the
fact that this isomer is relatively more hydrophobic (e.g. partition
coefficient α-Toc = 3.36 vs γ-Toc = 3.14), with three methylated
group on the chromanol ring as opposed to two for γ-Toc.(18) Thus
the relatively greater affinity of α-Toc with the non-polar phase
enables superior localization with the interface where propagation
of lipid oxidation occurs.
The finding that the ascorbic acid content of human milk was
negatively correlated with the hexanal content indicates a potential
role for vitamin C in suppressing lipid oxidation reactions in milk.
However, unlike α-Toc, there was no significant relationship
found between total vitamin C in human milk and TAC measured
by the ORACFL assay. The affinity of ascorbic acid to scavenge
peroxyl radicals that are generated in the ORACFL assay is only
30–50% that of the Toc analog Trolox.(19,20) Considering that
antioxidant properties of ascorbic acid are basically attributed to
the electron donation, or by scavenging of singlet oxygen, it is
understandable that ascorbic acid would not compare with vitamin
E to sequester the peroxyl radicals generated in the ORACFL assay.
The role of ascorbic acid in human milk to prevent oxidation
reactions works through its affinity to prevent the initiation of lipid
oxidation by neutralization of singlet oxygen, or by regenerating
the tocopheroxyl radical that can be produced during the lipid
oxidation cascade to its native form.(21)
It is important to note that although α-Toc is significantly
correlated with higher ORAC values and lower hexanal concentra-
tion, no significant relationship was found between ORAC value
and the hexanal content. Our finding agrees with Turoli et al.(9)
that the total antioxidant capacity of milk did not correspond to
larger presence of peroxidation products. In mother’s milk, the
TAC should refer to the sum of activities derived from active
enzymatic antioxidant systems (e.g. catalase, glutathione per-
oxidase), non-enzymatic antioxidants such as vitamins E and C
and the presence of other bioactive factors (e.g. lactoferrin, uric
acid).(9,11,22) ORACFL assay, as the case with other free radical
scavenging assays that have been used to measure antioxidant
capacity of mother’s milk is limited to measuring the activity of
components in milk that act as antioxidants by scavenging of
peroxyl radicals. We caution therefore that the use of ORACFL for
measuring antioxidant capacity is limited by its affinity to only
Fig. 5. Hexanal and pentanal generation by treatment of milk at 50°C
for 24 h as detected using static headspace gas chromatography.
Fig. 6. The aldehyde profile of human milk containing low vitamin C
content (A) and high vitamin C content (B).doi: 10.3164/jcbn.10 142
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characterize those components that scavenge free radicals, and not
the net generation of lipid oxidation products. Hexanal in milk
representing secondary products of lipid oxidation was found to be
a sensitive measure for characterizing the oxidative status of
breast milk.
The Holder pasteurization method is commonly performed in
human milk banks and involves heating milk at 62.5°C for
30 min.(4) We determined the effect of Holder pasteurization on the
formation of hexanal as an index of lipid oxidation, as well as
determining ORACFL values for assessing changes in antioxidant
capacity. Malondialdehyde concentration was also measured level
in human milk by TBA assay as one of the most commonly used
end-point measure of lipid oxidation.(23) Collectively, pasteuriza-
tion did not affect the oxidative status of human milk, as measured
by all parameters including the ORACFL values, MDA and hexanal
concentrations. Pasteurization as currently practiced, in general
preserves the oxidative state of human milk. Of particular interest
however, was the observation made on two individual milk
samples that showed an increase in hexanal level after pasteuriza-
tion and a corresponding low concentration of vitamin C (0–8.5
μg/ml) (Fig. 6). Concomitant decreases in ORACFL values were
also observed in these milk samples, demonstrating that the
increased generation of hexanal was relevant at identifying
ongoing lipid peroxidation in samples that also had reduced
antioxidant capacity. The marked increase in lipid oxidation in
these particular milk samples that had undergone pasteurization
was not detected when malondialdehyde was used as the end-point
measure of peroxidation (Table 3). The fact that MDA artifacts
can be formed during the heating step involving the TBA assay(23)
further states that relying on TBARS as a measure of lipid
oxidation will produce greater inaccuracy than measuring hexanal
content of mother’s milk.
Conclusion
Hexanal was found to be a reliable indicator of lipid oxidation
in human milk. A novel approach to quantify hexanal from human
milk that required adjusting for the varying fat content is reported.
Alpha- tocopherol was the only tocopherol isomer that was
correlated with controlling lipid oxidation. At the same time,
only α-Toc and vitamin C were correlated in preventing hexanal
formation in human milk in individual milk samples. Pasteuriza-
tion of human milk only affected milk that contained extremely
low levels of vitamin C.
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